Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RPL554 add-on to tiotropium/olodaterol in COPD (3-way crossover)
2018-001037-41Phase 2Completed
- Sponsor
- Verona Pharma
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ensifentrine in chronic obstructive pulmonary disease (COPD), sponsored by Verona Pharma. Started Jun 2018; status: completed.
02
Drugs
ensifentrine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2018-001037-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001037-41.